Immunotherapy significantly increases the number of patients free from bowel cancer
An immunotherapy drug given before surgery instead of chemotherapy meant that over ten times more patients with a certain genetic...
Nathaniel Bowman is a Scienmag editorial specialist profile for Precision Oncology coverage.
An immunotherapy drug given before surgery instead of chemotherapy meant that over ten times more patients with a certain genetic...
CHICAGO – While CAR T cell therapy has revolutionized treatment for many blood cancers, including non-Hodgkin lymphoma (NHL), many patients...
About The Study: This study found that comparable levels of sensitivity and specificity as reported for the multitarget stool RNA (mt-sRNA)...
WASHINGTON --- Clinicians at Georgetown University’s Lombardi Comprehensive Cancer Center reported promising preliminary findings based on outcomes in the first...
Boston – Dana-Farber Cancer Institute researchers are leading 3 separate studies with encouraging results in treating patients with central nervous...
TAMPA, Fla., and PLEASANTON, Calif. — Moffitt Cancer Center, a world-renowned cancer treatment and research center, and Virogen Biotechnology Inc.,...
About The Study: Ivonescimab plus chemotherapy significantly improved progression-free survival with tolerable safety profile in patients with non–small cell lung cancer...
Novel CAR T cell therapy obe-cel yields strong remission rates in adults with relapsed or refractory B-ALL (Abstract 6504) Novel...
Prostate cancer (PC) is a significant health concern, being the second leading cause of death among American men. The standard...
For centuries, civilizations have used naturally occurring, inorganic materials for their perceived healing properties. Egyptians thought green copper ore helped...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine